Covered recipient · General Payments record
MAIKE T BLAYA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$2,761.62
- Reported across 82 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $883.17 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $502.50 | 19 |
| PFIZER INC. | $182.90 | 10 |
| Lundbeck LLC | $68.42 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.66 | 1 |
| Alexion Pharmaceuticals, Inc. | $25.60 | 1 |
| TG THERAPEUTICS, INC. | $24.08 | 1 |
| Genentech USA, Inc. | $22.79 | 1 |
| Biogen, Inc. | $22.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.84 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336252 | CMS |
| ABBVIE INC. | $16.99 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336254 | CMS |
| ABBVIE INC. | $23.34 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336256 | CMS |
| ABBVIE INC. | $19.00 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336258 | CMS |
| ABBVIE INC. | $12.76 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336260 | CMS |
| ABBVIE INC. | $32.60 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336262 | CMS |
| ABBVIE INC. | $11.00 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336264 | CMS |
| ABBVIE INC. | $25.27 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336266 | CMS |
| ABBVIE INC. | $22.13 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336268 | CMS |
| ABBVIE INC. | $34.27 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336270 | CMS |
| ABBVIE INC. | $27.24 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336272 | CMS |
| ABBVIE INC. | $22.21 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336274 | CMS |
| ABBVIE INC. | $29.24 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336276 | CMS |
| ABBVIE INC. | $27.77 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336278 | CMS |
| ABBVIE INC. | $20.65 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336280 | CMS |
| ABBVIE INC. | $16.84 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336282 | CMS |
| ABBVIE INC. | $11.11 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336284 | CMS |
| ABBVIE INC. | $105.51 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336286 | CMS |
| ABBVIE INC. | $23.73 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103336288 | CMS |
| Alexion Pharmaceuticals, Inc. | $25.60 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094006511 | CMS |
| Biogen, Inc. | $22.22 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104845922 | CMS |
| Genentech USA, Inc. | $22.79 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133058306 | CMS |
| Lundbeck LLC | $68.42 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145898348 | CMS |
| Novartis Pharmaceuticals Corporation | $34.66 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086619567 | CMS |
| PFIZER INC. | $21.47 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131123602 | CMS |
| PFIZER INC. | $10.06 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131897139 | CMS |
| PFIZER INC. | $13.30 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131270539 | CMS |
| PFIZER INC. | $21.05 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131290522 | CMS |
| PFIZER INC. | $20.74 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131378237 | CMS |
| PFIZER INC. | $18.52 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131494210 | CMS |
| PFIZER INC. | $22.45 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131677817 | CMS |
| PFIZER INC. | $17.76 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131862661 | CMS |
| PFIZER INC. | $16.88 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131948522 | CMS |
| PFIZER INC. | $20.67 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132089803 | CMS |
| TG Therapeutics, Inc. | $24.08 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136882065 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.